Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

In vitro removal of beta-2-microglobulin from uremic blood with an immunoadsorption wall.

Yang TH, Lin BJ, Ma YL, Chou KJ.

Artif Organs. 2012 Jan;36(1):78-86. doi: 10.1111/j.1525-1594.2011.01294.x. Epub 2011 Jul 13.

PMID:
21752037
2.

Dialysis related amyloidosis: a disease of chronic retention and inflammation?

Floege J, Schäffer J, Koch KM, Shaldon S.

Kidney Int Suppl. 1992 Oct;38:S78-85. Review.

PMID:
1405384
3.

Beta 2-microglobulin serum concentration and associated amyloidosis in dialysis patients.

Stein G, Schneider A, Thoss K, Ritz E, Schaefer K, Hüller M, Sperschneider H, Marzoll I.

Nephrol Dial Transplant. 1991;6 Suppl 3:57-61.

PMID:
1775270
4.

Modalities for the removal of beta 2-microglobulin from blood.

Ameer GA.

Semin Dial. 2001 Mar-Apr;14(2):103-6.

PMID:
11264776
5.

Assessment of the stability of an immunoadsorbent for the extracorporeal removal of Beta-2-microglobulin from blood.

Daniels CM, Woolverton EM, Sprague SM, Ameer GA.

Blood Purif. 2005;23(4):287-97.

PMID:
15942167
6.

New ligand coupling procedure for formation of an immunoadsorption wall.

Yang TH, Feng CL.

ASAIO J. 2007 Mar-Apr;53(2):201-6.

PMID:
17413561
7.

First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis.

Ronco C, Brendolan A, Winchester JF, Golds E, Clemmer J, Polaschegg HD, Muller TE, La Greca G, Levin NW.

Blood Purif. 2001;19(2):260-3. No abstract available.

PMID:
11150821
8.

[Prevention of dialysis-related amyloidosis].

Yamamoto S, Gejyo F, Kazama JJ.

Nihon Rinsho. 2004 Jun;62 Suppl 6:353-6. Review. Japanese. No abstract available.

PMID:
15250323
9.

Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.

McCarthy JT, Williams AW, Johnson WJ.

J Lab Clin Med. 1994 Apr;123(4):495-505.

PMID:
8144998
10.

Role of uremic and endothelial factors in the development of beta 2-microglobulin amyloidosis.

Nakashima Y, Akizawa T, Nagai T, Koshikawa S.

Kidney Int Suppl. 1993 Jun;41:S88-95.

PMID:
8320954
11.

Can the nephrologist prevent dialysis-related amyloidosis?

Zingraff J, Drüeke T.

Am J Kidney Dis. 1991 Jul;18(1):1-11. Review.

PMID:
2063840
12.

On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.

Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, D'Haenens P.

Nephrol Dial Transplant. 2000;15 Suppl 1:49-54.

PMID:
10737167
13.

Beta-2-microglobulin as a uremic toxin: the Japanese experience.

Fujimori A.

Contrib Nephrol. 2011;168:129-33. doi: 10.1159/000321751. Epub 2010 Oct 7.

PMID:
20938132
14.

Beta-2 microglobulin in ESRD: an in-depth review.

Winchester JF, Salsberg JA, Levin NW.

Adv Ren Replace Ther. 2003 Oct;10(4):279-309. Review.

PMID:
14681859
15.

Nontransplant therapy for dialysis-related amyloidosis.

Copley JB, Lindberg JS.

Semin Dial. 2001 Mar-Apr;14(2):94-8. Review.

PMID:
11264774
16.

Behavior of beta 2-microglobulin (B2-m) serum levels in uremic patients.

Mioli VA, Balestra E, Bibiano L, Dellabella S, Fanciulli E, Gaffi G, Perilli A, Petroselli F, Ricciatti AM, Carletti P.

Int J Artif Organs. 1994 Nov;17(11):576-80.

PMID:
7744516
17.

[Kidney and bone update : the 5-year history and future of CKD-MBD. Treatment for dialysis-related amyloidosis update].

Yamamoto S, Kazama JJ, Narita I.

Clin Calcium. 2012 Jul;22(7):1089-98. doi: CliCa120710891098. Review. Japanese.

PMID:
22750942
18.

Beta-2-microglobulin amyloidosis and osteo-articular pathology of the uremic patient on regular dialysis.

Brancaccio D, Anelli A, Gallieni M, Padovese P, Coggi G, Uslenghi C.

Contrib Nephrol. 1990;77:177-86. Review. No abstract available.

PMID:
2188786
19.

Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.

Gejyo F, Homma N, Arakawa M.

Kidney Int Suppl. 1993 Jun;41:S78-82. Review.

PMID:
8320951
20.

Statistical and parametric analysis of beta-2-microglobulin removal from uremic patients in high flux hemodialysis.

Lee CJ, Hsiong CH, Chang YL, Cheng CH, Lian JD.

ASAIO J. 1994 Jan-Mar;40(1):62-6.

PMID:
8186494

Supplemental Content

Support Center